An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)
Clinical trial NCT02451839 · COMPLETED
Trial details
- NCT number
- NCT02451839
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-06
- Primary completion
- 2017-12-05
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.